Crossmark

Challenges of chimeric antigen receptor-T/natural killer cell therapy in the treatment of solid tumors: focus on colorectal cancer and evaluation of combination therapies

Crossref DOI link: https://doi.org/10.1007/s11010-022-04568-0

Published Online: 2022-10-03

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Haifeng

Pan, Weihuo
License Information

Text and Data Mining valid from 2022-10-03

Version of Record valid from 2022-10-03
More Information

Article History

Received: 7 April 2022

Accepted: 16 September 2022

First Online: 3 October 2022

Declarations

:

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

: Not applicable.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below